Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Home Blood Pressure Monitoring
Author(s): Jacob George , Thomas M MacDonald Added: 3 years ago
Hypertension increases the risk of heart attack, stroke, kidney disease, and heart failure1 and is the leading preventable risk factor for global cardiovascular (CV) disease burden worldwide.2 At ages 40–69 years, each increase of 20 mmHg in systolic blood pressure (BP) is associated with more than a doubling of the baseline mortality rate from cardiovascular disease (CVD).3 However, despite the… View more

Heart Failure
The Role of Nocturnal Blood Pressure and Sleep Quality in Hypertension Management
Author(s): Francesco P Cappuccio Added: 3 years ago
Hypertension is a major independent risk factor for cardiovascular (CV) diseases, including cardiac death, coronary heart disease, heart failure, stroke and chronic kidney disease. Therefore, early diagnosis, prevention and optimal management of hypertension is essential.1 Hypertension poses a growing public health burden: the number of adults with elevated blood pressure (BP) increased from 594… View more

Prevention & Chronic Conditions
Foreword

Article

Author(s): Juan Carlos Kaski Added: 3 years ago
This issue of European Cardiology Review features articles of major practical relevance as well as reviews and expert opinions on topics of pathophysiological importance. J Dungu reviews diagnostic and prognostic issues regarding cardiac amyloid highlighting the importance of imaging for the diagnosis and management of the condition. M Sheppard gives a pathologist’s perspective on stress… View more

Prevention & Chronic Conditions
Author(s): Thomas Kahan Added: 3 years ago
High blood pressure is the major risk factor for disease and premature death worldwide.1 The associations between blood pressure and fatal coronary artery disease and fatal stroke have been well demonstrated.2 Also, associations between blood pressure and morbidity and mortality on specific cardiovascular disease conditions in different age groups, and results concerning the lifetime risk for… View more

Standards & Guidelines

Prevention & Chronic Conditions
Most Recent Trials and Advances in Hypertension
Author(s): Elías Martínez Rey-Rañal , Alberto Cordero Added: 1 year ago

Prevention & Chronic Conditions
Pre-eclampsia and CVD
Author(s): Veronica Giorgione , Matthew Cauldwell , Basky Thilaganathan Added: 10 months ago

Demographic

Prevention & Chronic Conditions
Author(s): John Anderson , Nicola Donnelly Added: 3 years ago
A range of treatments have been developed for the management of cardiac arrhythmias. These include antiarrhythmic drugs, artificial pacemakers, implanted cardiac defibrillators and ablation of damaged or malfunctioning cardiac tissue. However, to allow a physician to choose the most suitable course of treatment for a patient, it is important that the correct diagnosis be made in an appropriate… View more

Electrophysiology & Arrhythmia
Remote Monitoring of Patients with Implanted Cardiac Devices - A Review
Author(s): Bosede A Afolabi , Fred M Kusumoto Added: 3 years ago
Since the first implantable pacemaker was introduced in 1958, electronic devices designed to treat cardiac problems have experienced technological leaps. A rapidly expanding number of patients depend on this technology.1 Cardiovascular implantable electronic devices (CIEDs) now include implantable cardioverter defibrillators (ICDs), pacemakers (PMs), cardiac resynchronisation therapy (CRT)… View more

Electrophysiology & Arrhythmia

Digital Health
Author(s): Steven Podd , Jacqueline Hunt , Neil Sulke Added: 3 years ago
Vasovagal syncope (VVS) is most common cause of syncope,1 with 37 % of the population suffering at least one attack during their life time.2 Head up tilt-table testing (HUTT) was first evaluated and used for the diagnosis of VVS in 1986.3–4 Prior to this, diagnosis relied purely on the clinical history and exclusion of other conditions. With almost 40 % of patients with VVS experiencing no… View more

Heart Failure

Electrophysiology & Arrhythmia
AHA 22: PRECISION: Aprocitentan in the Treatment of Resistant Hypertension
Author(s): Markus P Schlaich Added: 1 year ago
AHA 2022 — Dr Markus P Schlaich (University of Western Australia, AU) joins us to discuss the key findings from the PRECISION trial (NCT03541174).This randomized, phase 3 study assessed the sustained blood pressure lowering effect of a dual endothelin receptor antagonist, aprocitentan (Idorsia Pharmaceuticals Ltd.) in resistant hypertension. Presented first at AHA 22, the trial showed that… View more

Prevention & Chronic Conditions